APG Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132M Buy
1,197,619
+203,010
+20% +$26.7M 0.33% 64
2026
Q1
$120M Buy
994,609
+12,124
+1% +$1.7M 0.38% 56
2025
Q4
$103M Sell
982,485
-73,086
-7% -$8.88M 0.29% 61
2025
Q3
$99.7M Sell
1,055,571
-103,565
-9% -$11.8M 0.28% 67
2025
Q2
$109M Buy
1,159,136
+125,884
+12% +$13.4M 0.32% 59
2025
Q1
$107M Sell
1,033,252
-196,517
-16% -$20.3M 0.33% 62
2024
Q4
$110M Buy
1,229,769
+670,236
+120% +$60.3M 0.31% 66
2024
Q3
$42M Sell
559,533
-1,310,027
-70% -$100M 0.28% 61
2024
Q2
$120M Sell
1,869,560
-517,467
-22% -$34.5M 0.21% 110
2024
Q1
$162M Buy
2,387,027
+17,099
+0.7% +$1.31M 0.28% 79
2023
Q4
$174M Sell
2,369,928
-242,620
-9% -$18.9M 0.34% 67
2023
Q3
$196M Sell
2,612,548
-41,493
-2% -$3.19M 0.4% 59
2023
Q2
$187M Buy
2,654,041
+65,744
+3% +$5.24M 0.38% 63
2023
Q1
$198M Sell
2,588,297
-310,689
-11% -$25.7M 0.42% 57
2022
Q4
$249M Buy
2,898,986
+941,459
+48% +$74.6M 0.47% 49
2022
Q3
$123M Sell
1,957,527
-1,035,617
-35% -$65.3M 0.32% 73
2022
Q2
$177M Sell
2,993,144
-12,397
-0.4% -$768K 0.41% 59
2022
Q1
$161M Sell
3,005,541
-327,500
-10% -$20.9M 0.3% 90
2021
Q4
$213M Sell
3,333,041
-25,000
-0.7% -$1.72M 0.36% 72
2021
Q3
$202M Sell
3,358,041
-200,700
-6% -$14.1M 0.36% 73
2021
Q2
$207M Sell
3,558,741
-228,378
-6% -$15.2M 0.35% 74
2021
Q1
$208M Sell
3,787,119
-200,791
-5% -$12.9M 0.36% 68
2020
Q4
$190M Buy
3,987,910
+1,155,168
+41% +$69.7M 0.31% 76
2020
Q3
$153M Buy
2,832,742
+47,352
+2% +$3.28M 0.26% 96
2020
Q2
$191M Buy
2,785,390
+1,652,188
+146% +$127M 0.35% 66
2020
Q1
$84.7M Buy
1,133,202
+417,845
+58% +$28.9M 0.17% 140
2019
Q4
$41.4M Buy
715,357
+149,669
+26% +$9.75M 0.07% 302
2019
Q3
$32.9M Buy
565,688
+138,208
+32% +$9.03M 0.05% 338
2019
Q2
$25.4M Sell
427,480
-1,989,695
-82% -$131M 0.04% 372
2019
Q1
$140M Sell
2,417,175
-2,619,655
-52% -$174M 0.26% 118
2018
Q4
$276M Sell
5,036,830
-190,200
-4% -$13.3M 0.56% 43
2018
Q3
$347M Buy
5,227,030
+21,700
+0.4% +$1.64M 0.61% 36
2018
Q2
$316M Sell
5,205,330
-297,800
-5% -$21M 0.58% 40
2018
Q1
$337M Sell
5,503,130
-275,900
-5% -$21.9M 0.65% 24
2017
Q4
$345M Buy
5,779,030
+24,816
+0.4% +$1.88M 0.63% 28
2017
Q3
$466M Buy
5,754,214
+222,200
+4% +$17M 0.77% 17
2017
Q2
$392M Sell
5,532,014
-391,412
-7% -$26M 0.71% 24
2017
Q1
$402M Buy
5,923,426
+849,741
+17% +$59.8M 0.74% 22
2016
Q4
$344M Buy
5,073,685
+225,500
+5% +$16.8M 0.65% 26
2016
Q3
$384M Buy
4,848,185
+1,119,000
+30% +$90.9M 0.67% 28
2016
Q2
$311M Buy
3,729,185
+731,400
+24% +$64.9M 0.59% 31
2016
Q1
$275M Buy
2,997,785
+513,891
+21% +$46.3M 0.57% 34
2015
Q4
$251M Sell
2,483,894
-65,798
-3% -$6.85M 0.58% 38
2015
Q3
$250M Buy
2,549,692
+198,241
+8% +$22M 0.57% 39
2015
Q2
$275M Buy
2,351,451
+587,002
+33% +$64.1M 0.55% 36
2015
Q1
$173M Sell
1,764,449
-232,252
-12% -$23.6M 0.36% 76
2014
Q4
$188M Buy
1,996,701
+125,686
+7% +$13M 0.36% 74
2014
Q3
$199M Buy
1,871,015
+178,007
+11% +$17.4M 0.4% 52
2014
Q2
$140M Buy
1,693,008
+87,595
+5% +$6.82M 0.3% 89
2014
Q1
$114M Buy
1,605,413
+114,746
+8% +$9M 0.3% 87
2013
Q4
$112M Sell
1,490,667
-223,670
-13% -$15.6M 0.33% 81
2013
Q3
$108M Sell
1,714,337
-332,753
-16% -$19.9M 0.34% 80
2013
Q2
$105M Buy
+2,047,090
New +$107M 0.33% 82

Other funds holding GILD

APG Asset Management's GILD Position: Q2 2026 in Review

APG Asset Management increased its Gilead Sciences (GILD) stake by 20% in Q2 2026, buying an estimated $26.7M and bringing the position to 1,197,619 shares worth $132M. The position accounts for 0.33% of the portfolio, ranked #64.

APG Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $466M in Q3 2017. 1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • APG Asset Management held 1,197,619 shares of Gilead Sciences worth $132M as of Q2 2026.
  • APG Asset Management bought 203,010 Gilead Sciences shares in Q2 2026, an estimated $26.7M.
  • Gilead Sciences made up 0.33% of APG Asset Management's portfolio in Q2 2026, its #64 holding.
  • APG Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • APG Asset Management's Gilead Sciences position peaked at $466M in Q3 2017.
  • 1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.